Celadon prospers as its trucks cruise the NAFTA trail

Article Abstract:

Celadon Group Inc., a 13 yeard old trucking company, is poised to benefit from rapid growth in transborder traffic linking the industrial Midwest US and Mexico, along with rival Contract Freighters Inc., according to analysts at Furman Selz LLC. The company's revenues have more than doubled since 1994, when Celadon went public, following passage of NAFTA. Celadon, which had been formed to transport auto components to a Mexican Chrysler plant, expanded its capacity last month with the $19 million purchase of Canadian trucking firm Gerth Transport. Celadon also transports auto components to Mexico for Daimler-Benz AG's Freightliner truck plant and auto factories of Volkswagen AG and Mitsubishi Motors Corp. Celadon carries other products northward for companies such as Mattel Inc., General Electric Co. and Pier 1 Imports Inc.

Comment:

Trucking company benefits from NAFTA agreement and growth in US/Mexico shipping

Trucking, General Freight Trucking, Marketing procedures, Industry Market Data, Article, Celadon Group Inc., Contract Freighters Inc.

---

Sara Lee Corp. recalls meat, plans charge

Article Abstract:

Sara Lee Corp. voluntarily recalled all its meat products put out from its Zeeland, Michigan, plant and has stopped almost all production there for the time being. Four people have died from tainted hot dogs that might have come from this Michigan plant. More and more, meat packers would rather do the recall early on than risk even higher costs in the courtroom.

Comment:

Voluntary recall by company before listeria contamination is confirmed as its own

Product standards, safety, & recalls, Meat Processed from Carcasses, Sausages and other prepared meats, Frankfurters & Wieners, Product defects and recalls, Meat industry, Contamination, Sara Lee Corp., SLE, Frankfurters

---

Lilly's net jumped 24% in 4th quarter as new drugs offset Prozac slowdown

Article Abstract:

Eli Lilly & Co. reported a profitable 4th quarter and year with help from relatively new drugs. Net income for 1998 came to $2.10 billion and sales increased 16% over 1997. Prozac sales went up only 8% in the fourth quarter while Zyprexa rose 62% and Gemzar rose by 78%.

Comment:

Full-year sales were up 16% over l997

Sales, profits & dividends, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Pharmaceutical industry, Finance, Eli Lilly and Co., LLY

Similar abstracts:

• Abstracts: SBC emerging as a bull in the F.C.C.'s China shop. Court bars Bells from offering long distance
• Abstracts: New proposal would alter stock sales to employees. Lawsuits by rivals accuse textile maker of corporate espionage
• Abstracts: Home builders begin to see the advantages of consolidation. 'South Park' creators plan cartoon series for the Web
• Abstracts: Rockwell plans staff cuts of up to 10%. Broadcom Corp. plans public offering, with most of sale to come from insiders
• Abstracts: American Home withdraws new drug to ease pain, after death of 4 patients. Strong Viagra sales propel Pfizer to 37% gain in quarterly profit

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.